Unraveling the Immune Signature of Herpes Zoster: Insights Into the Pathophysiology and Human Leukocyte Antigen Risk Profile
Authors:
- 9 January 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 230 (3) , 706-715
Abstract
The varicella-zoster virus (VZV) infects >95% of the population. VZV reactivation causes herpes zoster (HZ), known as shingles, primarily affecting the elderly and individuals who are immunocompromised. However, HZ can occur in otherwise healthy individuals. We analyzed the immune signature and risk profile in patients with HZ using a genome-wide association study across different UK Biobank HZ cohorts. Additionally, we conducted one of the largest HZ human leukocyte antigen association studies to date, coupled with transcriptomic analysis of pathways underlying HZ susceptibility. Our findings highlight the significance of the major histocompatibility complex locus for HZ development, identifying 5 protective and 4 risk human leukocyte antigen alleles. This demonstrates that HZ susceptibility is largely governed by variations in the major histocompatibility complex. Furthermore, functional analyses revealed the upregulation of type I interferon and adaptive immune responses. These findings provide fresh molecular insights into the pathophysiology and activation of innate and adaptive immune responses triggered by symptomatic VZV reactivation.Keywords
This publication has 45 references indexed in Scilit:
- STAT2 deficiency and susceptibility to viral illness in humansProceedings of the National Academy of Sciences, 2013
- The health and economic burden of chickenpox and herpes zoster in BelgiumEpidemiology and Infection, 2012
- Exploring the Impact of Exposure to Primary Varicella in Children on Varicella-Zoster Virus Immunity of ParentsViral Immunology, 2011
- THE IMMUNE SYSTEM AND THE INFLAMMATORY RESPONSE2005
- Decline in Varicella‐Zoster Virus (VZV)–Specific Cell‐Mediated Immunity with Increasing Age and Boosting with a High‐Dose VZV VaccineThe Journal of Infectious Diseases, 2003
- Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoproteinEuropean Journal of Immunology, 2002
- Association of HLA-A*3303-B*4403-DRB1*1302 haplotype, but not of TNFA promoter and NKp30 polymorphism, with postherpetic neuralgia (PHN) in the Japanese populationGenes & Immunity, 2002
- Viruses and interferon: a fight for supremacyNature Reviews Immunology, 2002
- Role of early cytokines, including alpha and beta interferons (IFN-α\β), in innate and adaptive immune responses to viral infectionsSeminars in Immunology, 1998
- Herpes Zoster-Varicella Infections in Immunosuppressed PatientsAnnals of Internal Medicine, 1978